IR Information
About Our Company
Our Vision
Management
Corporate Information
Our History
About Our Business
Business Model
R&D Pipelines
News
Policy
Privacy Policy
Anonymously Processing Informations
IR News
IR News
Management Information
IR Library
Other IR Information
FAQ
Japanese
TOP
>
IR News
IR News
2024.09.12
Timely Disclosure
Notice of Acquisition and Cancellation of Stock Acquisition Rights (Stock Options)
(205KB)
2024.09.10
Timely Disclosure
Announcement of notification of selection for the Japan Agency for Medical Research and Development (AMED) Smart Bio Drug Discovery Research Support Program
(113KB)
2024.09.02
Timely Disclosure
Announcement of Initiation of PAI-1 inhibitor RS5614 for malignant melanoma designated as Orphan Drug
(150KB)
2024.08.30
Timely Disclosure
the joint R&D agreement for artificial intelligence (AI)-based softwares as medical devices (SaMD) with Taipei Medical Un
(86KB)
2024.08.19
Timely Disclosure
Announcement of Initiation of clinical performance trial of artificial intelligence (AI) to predict insulin dosage for diabetes patients
(118KB)
IR News List
Management Information
To Our Shareholders and Investors
Corporate Governance
IR Library
IR Library List
Financial Results
Presentation Materials
General Meeting of Shareholders Materials
Timely Disclosure Information
Other IR Information
Stock Information
IR Calendar
Disclosure Policy
Disclaimer
IR Contact
For IR inquiries, please contact us here.